Marquetta Faulkner, M.D.
Professor

Internal Medicine

327-6031
Fax (Fax)
1005 Dr. D.B. Todd Boulevard
Building
Office
Nashville, TN  37208

mfaulkner@mmc.edu

CV or Bio (PDF)

Stading JA, Chock AW, Skrabal MZ, Faulkner MA. Development of diabetes after gatifloxacin therapy. Am J Health Syst Pharm. 2005 Nov 1;62(21):2293-5.

Hilleman DE, Faulkner MA, Monaghan MS. Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia. Pharmacotherapy. 2004 Aug;24(8):1077-83.

Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med. 2004;34(5):293-306.

Faulkner MA, Hilleman DE. Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future. Pharmacotherapy. 2003 Oct;23(10):1300-15.

Faulkner MA, Bertoni JM, Lenz TL. Gabapentin for the treatment of tremor. Ann Pharmacother. 2003 Feb;37(2):282-6.

Faulkner MA, Hilleman DE. The economic impact of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2002 Mar;3(3):219-28.

Stading JA, Skrabal MZ, Faulkner MA. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors. Am J Health Syst Pharm. 2001 Nov 1;58(21):2076-80.

Faulkner MA, Hilleman DE, Destache CJ, Mooss AN. Potential influence of timing of low-density lipoprotein cholesterol evaluation in patients with acute coronary syndrome. Pharmacotherapy. 2001 Sep;21(9):1055-60.

Faulkner MA, Hilleman DE. Amlodipine/benazepril: fixed dose combination therapy for hypertension. Expert Opin Pharmacother. 2001 Jan;2(1):165-78.

Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000 Apr;20(4):410-6.

Hornbeck CL, Griffiths JC, Neborsky RJ, Faulkner MA. A gas chromatographic mass spectrometric chemical ionization assay for haloperidol with selected ion monitoring. Biomed Mass Spectrom. 1979 Oct;6(10):427-30.

Gallant DM, Bishop MP, Mouledoux A, Faulkner MA, Brisolara A, Swanson WA. The revolving-door alcoholic. An impasse in the treatment of the chronic alcoholic. Arch Gen Psychiatry. 1973 May;28(5):633-5.

Charters AC, Chandler JG, Flamant YM, Faulkner MA, Orloff MJ. Cyclic nucleotide regulation of gastric acid secretion. Surg Forum. 1973;24:361-3.

Gallant DM, Bishop MP, Faulkner MA, Simpson L, Cooper A, Lathrop D, Brisolara AM, Bossetta JR. A comparative evaluation of compulsory (group therapy and-or antabuse) and voluntary treatment of the chronic alcoholic munciple court offender. Psychosomatics. 1968 Nov-Dec;9(6):306-10.

Gallant DM, Bishop MP, Stoy B, Faulkner MA, Paternostro L. The value of a "first contact" group intake session in an alcoholism outpatient clinic: statistical confirmation. Psychosomatics. 1966 Nov-Dec;7(6):349-52.